Abstract Long-Acting Injectable Antipsychotics (LAIs) are used to overcome non-compliance
in psychoses, mainly schizophrenia spectrum disorders. We aimed to summarize available …

Background Non-adherence to medications is a major determinant of poor outcome in
bipolar disorder. Second-generation long-acting injectable (LAI) antipsychotics help ensure …

Relapse associated with multiple hospital readmissions of patients with chronic and severe
mental disorders, such as psychosis and bipolar disorder, is frequently associated with non …

Depot antipsychotics have been used as a strategy to reduce non-adherence to medications
in schizophrenia and bipolar disorder (BD). This article reviews the literature on the efficacy …

Poor adherence to pharmacotherapy during maintenance-phase treatment of bipolar
disorder is a common occurrence, exposing patients to a high risk of illness relapses …

Purpose To determining whether the addition of a long-acting injectable antipsychotic (LAI-
AP) has a positive effect on prognosis in bipolar disorder. Materials and methods Medical …

Objectives The maintenance phase of bipolar disorder is arguably the most important. The
aim of management during this time is to maintain wellness and prevent future episodes of …

Purpose: A high level of treatment adherence is essential in patients with bipolar disorder for
effective treatment, due to chronic progressive nature of the illness requiring maintenance …

Schizophrenia is a chronic, severe and recurrent brain disorder that requires continuous,
long-term treatment with antipsychotic medication to minimize relapse and provide clinical …

Bipolar disorder (BD) is a major psychiatric disorder that is easily misdiagnosed. Patient
adherence to a treatment regimen is of utmost importance for successful outcomes in BD …